Abstract
Aim: In this prospective observational study, we investigated the efficacy of Stoller afferent nerve stimulation (SANS) in subjects with overactive bladder who failed anticholinergic treatment.
Methods: Thirty-five subjects with overactive bladder who failed therapy with oxybutynin participated in this study. Treatment (n=35) was given once a week for 30 minutes for overall 10 weeks. In treatment, SANS device (Urosurge®) was used. Subjects were assessed with 3-day voiding diary, SEAPI quality of life questionnaires and cystometry before therapy after completion of therapy and at one-year follow-up.
Results: In 54% (n=19) of subjects complete recovery was obtained after treatment. Urgency and SEAPI were reduced significantly whereas urine volume increased significantly (p<0.01). Complete recovery was maintained in eight of the 19 subjects at one year.
Conclusions: SANS treatment has a short-term positive effect in patients with resistant overactive bladder. However, it was also established that efficacy was maintained at 1 year in only 23% of subjects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hashim H, Abrams P. (2004) Drug treatment of overactive: efficacy, cost and quality-of-life considerations. Drugs 64(15):1643
Abrams PH, Wein AJ. Introduction (2001) Overactive bladder and its treatment. Urology 55 (Suppl 5A): 1
Andersson KE. (2004) New pharmacologic targets for the treatment of the overactive bladder: an update. Urology. Mar;63(3 Suppl 1):32–41
Craggs M, Edhem I, Knight S, McFarlane J, Shah N (1998) Suppression of normal human voiding reflexes by electrical stimulation of the dorsal penile nerve. Eur Urol 33(Suppl.1):60
Shah N, Edhem I, Knight S, Shah J, Craggs M (1998) Acute suppression of provoked detrussor hyperreflexia by electrical stimulation of dorsal penile nerve. Eur Urol 33(Suppl.1):60
Raz S, Stothers LS, Chopra A (1996) Raz techniques for anterior vaginal wall repair. Female Urology, W.B. Saunders, Philadelphia
Blaivas JG, Appell RA, Fantl JA, et al. (1997) Standards of efficacy for evaluation of treatment outcomes in urinary incontinence: Recommendations of the Urodynamics Society. Neurourol Urodyn b;16:145–147
Ambrams P, Cardozo L, Fall M, et al (2002)The Standardisation of Terminology of lower Urinary tract function: Report from the standardization sub-committee of the İnternational Continence Society. Neurourol Urodyn 21:167–178
Eriksen BC, Bergmann S, Eik-Nes SH (1989) Maximal electrostimulation of the pelvic floor in female idiopathic detrussor instability and urge incontinence. Neurol Urodynam 8:219
Walsh IK, Johnston RS, Keane PF (1999) Transcutaneous sacral neurostimulation for irritative voiding dysfunction. Eur Urol 35:192
Groen J, Van Mastright R, Bosch JLHR (2001) Computerized assessment of detrussor instability in patients treated with sacral neuromodulation. J Urol 165:169
Stoller ML (2000) Afferent nerve stimulation for pelvic floor dysfunction. Eur Urol 37(Suppl. 2):33
Grovier FE, et al. (2001) Percutaneus afferent neuromodulation. Results of a multicenter study. J Urol 165:1193
Amarenco G, Ismael SS, Even-Schneider A, Raibaut P, Demaille-Wlodyka S. (2003) Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. J Urol 169(6):2210
Cappellano F, Bertapelle P, Spinelli M, et al. (2001) Quality of life assessment in patients who undergo sacral neuromodulation implantation for urge incontinence: An additional tool for evaluating out comes. J Urol 166:2277
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nuhoğlu, B., Fidan, V., Ayyıldız, A. et al. Stoller afferent nerve stimulation in woman with therapy resistant over active bladder; a 1-year follow up. Int Urogynecol J 17, 204–207 (2006). https://doi.org/10.1007/s00192-005-1370-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-005-1370-x